Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGMAR1 | Q99720 | 18/20 | 1.00 |
| ▸ | GRIN2D | O15399 | 14/20 | 1.00 |
| ▸ | GRIN3B | O60391 | 14/20 | 1.00 |
| ▸ | GRIN1 | Q05586 | 14/20 | 1.00 |
| ▸ | GRIN2A | Q12879 | 14/20 | 1.00 |
| ▸ | GRIN2B | Q13224 | 14/20 | 1.00 |
| ▸ | GRIN2C | Q14957 | 14/20 | 1.00 |
| ▸ | GRIN3A | Q8TCU5 | 14/20 | 1.00 |
| ▸ | MEN1 | O00255 | 1/20 | 1.00 |
| ▸ | PABPC1 | P11940 | 1/20 | 1.00 |
| ▸ | ALOX15 | P16050 | 1/20 | 1.00 |
| ▸ | TSHR | P16473 | 1/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 1/20 | 1.00 |
| ▸ | EBP | Q15125 | 1/20 | 1.00 |
| ▸ | TMEM97 | Q5BJF2 | 1/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ditolylguanidine SCHEMBL29364709 | 1.00 | SIGMAR1 (1.00) | SIGMAR1GRIN2DGRIN3BGRIN1GRIN2A | |
| Ditolylguanidine SCHEMBL80339 | 1.00 | SIGMAR1 (1.00) | SIGMAR1GRIN2DGRIN3BGRIN1GRIN2A | |
| Ditolylguanidine SCHEMBL3388414 | 1.00 | SIGMAR1 (1.00) | SIGMAR1GRIN2DGRIN3BGRIN1GRIN2A | |
| Ditolylguanidine SCHEMBL8862769 | 0.98 | SIGMAR1 (0.97) | SIGMAR1GRIN2DGRIN3BGRIN1GRIN2A | |
| SCHEMBL8873081 | 0.87 | SIGMAR1 (1.00) | SIGMAR1GRIN2DGRIN3BGRIN1GRIN2A | |
| SCHEMBL8875387 | 0.87 | SIGMAR1 (0.78) | SIGMAR1GRIN2DGRIN3BGRIN1GRIN2A | |
| SCHEMBL8874196 | 0.84 | SIGMAR1 (0.81) | SIGMAR1GRIN2DGRIN3BGRIN1GRIN2A | |
| SCHEMBL8873792 | 0.84 | SIGMAR1 (1.00) | SIGMAR1GRIN2DGRIN3BGRIN1GRIN2A | |
| SCHEMBL14861883 | 0.83 | SIGMAR1 (0.78) | SIGMAR1GRIN2DGRIN3BGRIN1GRIN2A | |
| Hydrochloric Acid SCHEMBL8874645 | 0.83 | SIGMAR1 (1.00) | SIGMAR1GRIN2DGRIN3BGRIN1GRIN2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 352 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12220771-B2 | Flux and solder paste | SENJU METAL INDUSTRY CO., LTD. (JP) | 2025-02-11 | — | — | US | claimed |
| US-20230263797-A1 | Mammalian Hybrid Pre-Autophagosomal Structure HyPAS and Compositions and Methods for the Treatment of Coronavirus Infections and Related Disease States | UNM RAINFOREST INNOVATIONS (US) | 2023-08-24 | — | — | US | claimed |
| WO-2023055751-A1 | MIXED SOLVENT HYDROGEL SYSTEM FOR WOUND HEALING | UNIVERSITY OF SOUTHERN CALIFORNIA (US) | 2023-04-06 | — | — | WO | claimed |
| US-11559763-B2 | Regenerable solvent mixtures for acid-gas separation | RESEARCH TRIANGLE INSTITUTE (US) | 2023-01-24 | — | — | US | claimed |
| EP-3683005-B1 | FLUX AND SOLDER PASTE | SENJU METAL INDUSTRY CO (JP) | 2022-01-26 | — | — | EP | claimed |
| US-20210146003-A1 | A NOVEL METHOD TO IMPROVE ADHESIVE STRENGTH OF REVERSIBLE POLYMERS AND HYDROGELS | UNIVERSITY OF SOUTHERN CALIFORNIA (US) | 2021-05-20 | — | — | US | claimed |
| US-10843298-B2 | Flux and solder paste | SENJU METAL INDUSTRY CO., LTD. (JP) | 2020-11-24 | — | — | US | claimed |
| EP-3683005-A1 | FLUX AND SOLDER PASTE | Senju Metal Industry Co., Ltd (JP) | 2020-07-22 | — | — | EP | claimed |
| WO-2018232384-A1 | A NOVEL METHOD TO IMPROVE ADHESIVE STRENGTH OF REVERSIBLE POLYMERS AND HYDROGELS | UNIVERSITY OF SOUTHERN CALIFORNIA (US) | 2018-12-20 | — | — | WO | claimed |
| WO-2018156883-A1 | METHODS OF TREATMENT FOR CANCER, STEROL HOMEOSTASIS, AND NEUROLOGICAL DISEASES | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2018-08-30 | — | — | WO | claimed |
| US-9839875-B2 | Regenerable solvent mixtures for acid-gas separation | RESEARCH TRIANGLE INSTITUTE (US) | 2017-12-12 | — | — | US | claimed |
| WO-2016138135-A1 | SIGMA-1 RECEPTOR MODULATORS FOR TREATING HUNTINGTON'S DISEASE | TEVA PHARMACEUTICALS INTERNATIONAL GMBH (CH) | 2016-09-01 | — | — | WO | claimed |
| EP-2611518-B1 | REGENERABLE IONIC LIQUID SOLVENTS FOR ACID-GAS SEPARATION | RES TRIANGLE INST (US) | 2016-08-24 | — | — | EP | claimed |
| EP-2611518-A1 | REGENERABLE IONIC LIQUID SOLVENTS FOR ACID -GAS SEPARATION | Research Triangle Institute (US) | 2013-07-10 | — | — | EP | claimed |
| US-20130164199-A1 | REGENERABLE SOLVENT MIXTURES FOR ACID-GAS SEPARATION | RESEARCH TRIANGLE INSTITUTE | 2013-06-27 | — | — | US | claimed |
| WO-2012031274-A1 | REGENERABLE IONIC LIQUID SOLVENTS FOR ACID -GAS SEPARATION | RESEARCH TRIANGLE INSTITUTE (US) | 2012-03-08 | — | — | WO | claimed |
| EP-0461252-B1 | THERMOPLASTIC ELASTOMERS BASED UPON CHLORINATED OR CHLOROSULFONATED POLYETHYLENE AND A CRYSTALLINE OLEFIN POLYMER | DOW CHEMICAL CO (US) | 1998-06-03 | — | — | EP | claimed |
| US-5230936-A | Chlorinated polyethylene, a mercaptotriazine. crosslinking agent, acid acceptor | DAISCO CO., LTD. (JP) | 1993-07-27 | — | — | US | claimed |
| US-4687756-A | DITHIOCARBAMOYL GROUP CONTAINING COMPOUND | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1987-08-18 | — | — | US | claimed |
| US-4288576-A | BASIC MATERIAL | HERCULES INCORPORATED (US) | 1981-09-08 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230263797-A1 | Mammalian Hybrid Pre-Autophagosomal Structure HyPAS and Compositions and Methods for the Treatment of Coronavirus Infections and Related Disease States | SARS1, SQSTM1, ATG4A | SIGMAR1 2480/4885GRIN2D 3581/4885GRIN3B 2217/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.